HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 207 filers reported holding HORIZON PHARMA PLC in Q2 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $26,731,000 | +38.6% | 1,011,369 | +2.5% | 0.04% | +29.4% |
| Q4 2018 | $19,285,000 | -9.2% | 986,967 | -9.1% | 0.03% | +9.7% |
| Q3 2018 | $21,249,000 | +11.9% | 1,085,206 | -5.4% | 0.03% | +10.7% |
| Q2 2018 | $18,993,000 | +382.4% | 1,146,890 | +313.7% | 0.03% | +366.7% |
| Q1 2018 | $3,937,000 | +256.0% | 277,244 | +265.8% | 0.01% | +200.0% |
| Q4 2017 | $1,106,000 | +12.7% | 75,800 | -2.1% | 0.00% | +100.0% |
| Q3 2017 | $981,000 | +371.6% | 77,390 | +342.0% | 0.00% | – |
| Q2 2017 | $208,000 | -15.8% | 17,510 | +5.0% | 0.00% | – |
| Q1 2017 | $247,000 | -6.1% | 16,680 | +2.6% | 0.00% | – |
| Q4 2016 | $263,000 | -42.7% | 16,260 | -35.8% | 0.00% | -100.0% |
| Q3 2016 | $459,000 | +92.1% | 25,344 | +74.8% | 0.00% | – |
| Q2 2016 | $239,000 | +2.1% | 14,500 | +60.7% | 0.00% | – |
| Q1 2015 | $234,000 | – | 9,021 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $59,421,000 | 38.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 12,259,875 | $425,908,000 | 14.19% |
| Broadfin Capital, LLC | 4,815,807 | $167,301,000 | 8.99% |
| JW Asset Management, LLC | 766,724 | $26,636,000 | 8.10% |
| Marble Arch Investments | 1,888,000 | $65,589,000 | 5.65% |
| HealthCor Management, L.P. | 3,200,000 | $111,168,000 | 5.60% |
| Beach Point Capital Management LP | 794,290 | $27,594,000 | 5.42% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,325,829 | $115,539,000 | 4.52% |
| Ratan Capital Management LP | 1,321,300 | $45,902,000 | 4.37% |
| Green Owl Capital Management, LLC | 130,000 | $4,516,000 | 3.22% |